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LABORATORY INVESTIGATION
Increased urinary excretion of PGE2 during inappropriate
antidiuresis induced by DDAVP
PATRICIA A. CRAVEN, JOSEPH G. VERBALIS, and FREDERICK R. DERUBERTIS
VA Medical Center and the University of Pittsburgh, Pittsburgh, Pennsylvania /5260, U.S.A.
Increased urinary excretion of PGE2 during inappropriate antidiureses
induced by DDAVP. Increased urinary prostaglandin E excretion
(Ul.,E,V) and renal production of PGE2 have been implicated in the
mediation of escape from inappropriate antidiuresis induced by vaso-
pressin (AVP). AVP-induced increases in PGE have been linked to its
pressor activity. We examined the effects of the non-pressor AVP
analogue, l,desamino-8-D-arginine vasopressin (DDAVP), on UPC;E,V
in a rat model of inappropriate antidiuresis in which the escape response
is not apparent. A dose of DDAVP known to cause antidiuresis (10
ng/hr), was given by osmotic minipump to rats during a water diuresis
established by ad libitum ingestion of 5% dextrose in water (DIW). This
dose of DDAVP reduced plasma sodium (PNJ) to 127 2 mEq/liter
within 24 hr. P[N+1 in controls given 5% D/W alone was 151 2. In the
first eight hr after DDAVP, U1,,V was fivefold higher than in control
animals, an increase which was sustained for 48 hrs. Plasma renin
(PRA) was threefold higher in control rats compared to rats that had
received DDAVP, consistent with volume expansion in the latter.
Despite declines in P(N+I and PRA and increased Up0,V in DDAVP
treated rats, evidence of escape from inappropriate antidiuresis (sec-
ondary decline in Uosm or rise in urine volume (V) or (NaI) was
lacking. Moreover, DDAVP induced similar fivefold increases in
UPGE,V when given to fluid deprived rats, demonstrating that increases
of UPc,F,V during inappropriate antidiuresis were not mediated by
volume expansion. Administration of indomethacin to volume repleted
DDAVP treated rats did not significantly increase Uosmol or decrease
V compared to values observed in rats receiving DDAVP alone. The
results indicate that an increase in U1,,V per se is not sufficient to
trigger escape from inappropriate antidiuresis. They also suggest that
increased U0,V can be mediated directly through the antidiuretic as
well as the pressor activity of AVP.
Numerous previous studies have implicated renal prostaglan-
dins (PGs) as modulators of the antidiuretic action of vasopres-
sin (AVP) [1—4]. Under certain conditions, inhibitors of PG
synthesis enhance the hydroosmotic action of AVP [5—81. AVP
causes increased PGE2 production in renal inner medullary
interstitial cells in culture, inner medullary slices in vitro and in
cultured cortical collecting duct epithelium and glomerular
mesangial cells [9—13]. AVP also increases urinary
pro.staglandin E excretion (UPUEV) in vivo [14—18]. Recent
studies from our laboratory have demonstrated that administra-
tion of AVP to rats during an established water diuresis initially
resulted in a transient decrease in UPGE,V concurrent with the
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initial antidiuretic response. This was followed by an increase in
UPGEV concurrent with escape from antidiuresis [141. These
observations led to the proposal that AVP-induced increases in
UPGE,V, and presumably renal PGE2 production, may cause
feedback inhibition of the hydroosmotic action of the hormone
and therefore may play a role in the mediation of escape from
antidiuresis [14]. The studies of Gross, Kim and Anderson have
also suggested a role for increased UPGF,V during the early
phase of escape from desmopressin, since desmopressin in-
creased UPGEV during early escape, and escape was delayed in
rats treated with indomethacin [19].
Observations in some target tissues, including inner medulla
[101. medullary interstitial cells in culture [20], glomerular
mesangial cells [13], and vascular smooth muscle cells in
culture [21], suggest that the ability of AVP to increase PGE2 is
linked to the pressor rather than to the antidiuretic activity of
the hormone. Studies in man have suggested that only high
doses of AVP, of sufficient magnitude to alter blood pressure,
are effective in increasing UPGE,V [17, 18]. Moreover, I-
desamino-8-D-arginine vasopressin (DDAVP), an analogue of
AVP with almost no pressor activity, did not mimic actions of
AVP to increase Up0,V in man [17, 18]. In rat inner medullary
interstitial cells in culture [9] and in slices of rat inner medulla
in vitro [10], no effect of DDAVP on PGE2 production has been
observed under conditions where increases in PGE2 in response
to AVP were clearly evident. Moreover, the ability of AVP to
increase PGE2 in several in vitro preparations and the perfused
rabbit kidney is suppressed by selective pressor antagonists of
AVP action [9, 10, 22]. Similar findings have been reported in
studies of glomerular mesangial cells [13] and vascular smooth
muscle cells [21] in culture, Despite findings in normal man and
in rat inner medullary preparations in vitro, some studies
conducted in rats I IS, 20, 23], or man [24] with central diabetes
insipidus (DI), and one study in normal rats [25] have reported
an increase in UpGF.;,V following DDAVP administration.
In the present study, we examined the effect of DDAVP on
in normal rats to assess the potential effect of volume
expansion in the expression of DDAVP stimulated UPGE,V.
Since previous studies have suggested some role for renal
prostaglandins in the mediation of escape from inappropriate
antidiuresis [14, 19], we further examined this question employ-
ing a different experimental model for inappropriate antidiuresis
in which escape has not been observed [26]. Our results suggest
an action of DDAVP to increase UPGF,V in the normal rat that
is independent of volume expansion. In addition, the marked
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increase in UPGE,V observed with DDAVP in the present study
did not induce any detectable escape from the inappropriate
antidiuresis, Thus, enhanced UPGE,V is not invariably accom-
panied by escape from antidiuresis under all pathophysiological
conditions, Because increased renal production of PGE2 per se
is not sufficient to mediate escape, this therefore implies that
other factors must be involved in the induction of this response.
Methods
Collection of urine and plasma
Female Sprague—Dawley rats (200 to 250 g) were studied in
groups of six. All rats were housed in individual metabolic
cages as previously described in detail [26]. Rats were fed a low
Na diet (TEKLAD #170950, 0.01% NaCI, Madison, Wiscon-
sin, USA) ad libitum for three days before the start of each
study. This diet and water were then either provided ad libitum
or withheld as indicated in the text. When stated, rats were
deprived of food and water, and after 24 hr were allowed ad
libitum 5% dextrose in water (DIW), which results in a mark-
edly increased fluid intake as previously described in detail [26].
Where indicated in the text, osmotic minipumps (Alzet Model
2001, Palo Alto, California, USA) containing DDAVP in sterile
0.9% NaCl were implanted subcutaneously along the back
under light ether anesthesia. The minipumps were primed in
0.9% NaC1 so that infusions began from the time of insertion.
The dose of DDAVP employed in the present studies (10 ng/hr)
is ten times higher than that required to produce maximal
antidiuresis using this agent, as has been previously reported
[26]. Control animals underwent sham surgery without
minipump insertion. In some experiments (Fig. I), rats were
decapitated and trunk blood collected. In other experiments
(Fig. 2) daily blood samples (2.0 mliter) were obtained via an
indwelling jugular catheter (PE-60 polyethylene tubing,
Clay—Adams, Parsippany, New York, USA) and the volume
replaced with 0.9% NaCI. Blood was placed in heparinized
tubes (143 units/tube, B-D vacutainer, Rutherford, New Jersey)
for determination of PlNa*] or in EDTA (1 mg/muter blood) for
determination of plasma renin. Blood samples were centrifuged
immediately and plasma stored at —20°C until assay. Urine was
collected at eight hr intervals in flasks maintained at 0 to 4°C
and stored at —20°C until assay. Urine osmolality was mea-
sured by freezing point depression (Advanced Instruments
Osmometer, Needham Heights, Massachusetts, USA).
Determination of PGE2
Prostaglandin E2 was determined in rat urine without prior
extraction using commercially available antiserum as previ-
ously described in detail [14].
Determination of plasma renin
A 0.2 mliter aliquot of plasma was mixed with 2 piiter
dimercaprol (1.7% in peanut oil), 2 piiter of 8 hydroxyquinoline
and 0.4 mliter of 50 mivi maleate pH 6.0. An aliquot was then
incubated at 37°C for one hr while the remainder of the sample
was maintained at 0°C. Angiotensin I (A-I) was then determined
by radioimmunoassay using commercially available reagents as
previously described in detail [27]. Values obtained in plasma
samples maintained at 0°C were subtracted from those obtained
Fig. 1. Effects of DDA VP on UPGE2V, Uosmol, V and fluid intake in rats
deprived of food and allowed free access to 5% DIW. Two groups of
rats were studied. Each rat was placed in an individual metabolic cage
at 8 A.M. and allowed free access to food and water for 24 hrs. Both
food and water were then removed and the rats allowed 5% D/W ad
libitum for the remainder of the study. At 16 hrs after the start of 5%
D/W, a basal 8 hr urine collection was begun. Following this urine
collection, osmotic minipumps delivering 10 ng/hr of DDAVP were
placed subcutaneously in one group of animals under light ether
anesthesia (0—0) as indicated by the arrow. The second group of
rats underwent sham surgery (•—•). Eight hour urine collections
were then continued for an additional 24 hrs. Results shown are means
SE of determinations on six rats in each group. Symbol is: * <0.05
compared to sham operated controls.
in plasma incubated at 37°C. Renin activity is expressed as ng
A-I generated per hr of incubation at 37°C per mliter of plasma.
Statistical analysis
Significance of differences between mean values was deter-
mined by Student's independent t-test.
Materials
DDAVP was purchased from USV Laboratories (Tarrytown,
New York, USA). Prostaglandin E antiserum was purchased
from Regis Chemical Co. (Morton Grove, Illinois, USA). Angi-
otensin I radioimmunoassay kits were obtained from New
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Fig. 2. Effects of the state of hydration on DDA VP—induced changes in
UPGE,V, Uosmol and V. Two groups of rats were studied. Each rat was
placed in an individual metabolic cage and allowed free access to food
and water. Jugular venous catheters were inserted to allow collection of
daily blood samples. After a 48 hr period of acclimatization, a blood
sample was obtained and 8 hr urine collections were begun at 4 P.M.
Blood was sampled daily at 4 P.M. and urine collected every 8 hrs for
the next three days. At 4 P.M., at the start of the second day of study,
osmotic minipumps delivering 10 ng/hr DDAVP were inserted subcu-
taneously in one group of animals under light ether anesthesia (O—O)
as indicated by the arrow. The second group of rats underwent sham
surgery (•—•). As indicated in the figure, food and water were
deprived 4 hrs before insertion of the osmotic minipump or sham
surgery. At 4 P.M. on the beginning of the third study day, all rats were
given 20 mliter 5% D/W i.p. An additional 30 mliter of 5% D/W was
supplied in the water bottle. At the end of the study, plasma was
obtained for PINaI determination and the rats were sacrificed. Results
shown are means SE of determinations on six (O—O) or 18 (•—
•) rats. Symbol is P < 0.05 compared to sham operated controls.
England Nuclear (Boston, Massachusetts, USA). The sources
of all other reagents have previously been reported [10, 14, 261.
Results
As illustrated in Figure 1, administration of DDAVP to rats
deprived of food and allowed free access of 5% D/W resulted in
a prompt fivefold increase in UF,V during the first eight hrs of
administration. This occurred concurrently with a marked
increase in urine osmolality (Uosmol) and a decrease in urine
volume (V). UPGE,V and Uosmol remained elevated and V
remained low during the next two eight hr urine collections, and
did not vary significantly from corresponding values obtained
during the first eight hrs after DDAVP. As is also shown in
Figure 1, no alterations in UPGEY or Uosmol were observed in
sham—operated control animals who were also deprived of food
5% D/W and allowed 5% D/W ad libitum. V of the sham—operated
control group varied with fluid intake, which as expected was
greater during the night than during the day. At the end of the
study, PINal in rats deprived of food and allowed free access to
5% D/W was reduced by 16% to 127 2 mEq/liter in the group
receiving DDAVP compared to the sham-operated control rats
(PINal = 151 2). Plasma renin activity was also markedly
reduced in the DDAVP treated rats compared to the group
which underwent sham surgery (sham, 92 18; DDAVP, 29
5 ng AI/mliter/hr, P < 0.01).
Previous studies in dog [28] and man [28—301 have suggested
that UPGE,V may increase with urine flow and/or volume
expansion. By contrast, in the rat a simple relationship between
V and UPGE,V has not been demonstrated [14, 311. Neverthe-
less, under certain conditions in the rat, UPEV has been
reported to vary directly with changes in urine flow rate: after
prolonged water deprivation, UPGE,V falls, but then transiently
rises with the marked increase in V which occurs when 5% D/W
is offered ad libitum to rats previously deprived of water [14].
As indicated above, in the present study, administration of
DDAVP to rats maintained on 5% D/W produced a rapid and
marked fall in 1Nai and plasma renin activity. This is due
primarily to water retention [26], and thus accompanied to some
degree by volume expansion. This conclusion is supported by
the concurrent decreases in plasma renin activity and P[Na]
observed in these rats. Accordingly, we examined the possibil-
ity that the increase in UPGE,V induced by DDAVP during
ingestion of 5% D/W was mediated indirectly by volume expan-
sion. Rats were allowed the same low Na diet and water ad
libitum until four hrs before the start of DDAVP infusion or
sham surgery. Food and water were then withheld for the first
24 hrs after DDAVP pump insertion or sham surgery. After 24
hrs, the rats were then given 20 mliter of 5% D/W i.p. and
allowed an additional 30 mliter 5% D/W without food for the
subsequent 24 hrs. As shown in Figure 2, UPGE,V did not
change significantly in the sham operated control rats during the
periods of ad libitum food and water intake, food and water
deprivation, or following i.p. 5% D/W plus ad libitum post
operative 5% D/W. By contrast, administration of DDAVP to
food and water deprived rats resulted in a four— to fivefold rise
in UPGE,V during the first eight hrs after the start of DDAVP
infusion, analogous to the results observed when DDAVP was
given during continuous ingestion of 5% D/W [14] (Fig. I).
Subsequent ad libitum access to 5% D/W did not influence
UPGE,V in rats treated with DDAVP compared to values
observed during the period of food and water deprivation. As is
also shown in Figure 2, changes in Uosmol and V induced by
deprivation of food and water were indistinguishable in rats
receiving DDAVP compared to sham operated controls. Fol-
lowing volume repletion with 5% D/W, Uosmol fell and V rose
markedly in sham—operated control rats. In contrast, these
parameters were not significantly changed after 5% D/W admin-
istration to DDAVP treated rats in comparison with values
observed in the same rats during the period of food and water
deprivation. tNa] was not different between the two groups
during ad libitum food and water intake (sham, 139 0.3;
DDAVP, 140 0.3 mEq/liter SE). With food and water
deprivation, [Na] increased modestly in both groups (sham,
147 1; DDAVP, 144 I mEq/liter, mean SE). Following
volume repletion with 5% D/W, P[Na]fell to 115 1 mEq/liter
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Table 1. Effects of indomethacin on DDA VP-induced alterations during different states of hydration
Urine volume
muter/S hrs
Fluid intake
mliier/8 hrs
Uosmol
mos,nollkg H20
Plasma [Na]
mEqiliter
UPGE2V
ng/8 hr
Day I
Ad lib. food and H,O
Group I 5 1 9 I 1464 294 143 1 45 6
Group II 4.3 0.7 8.5 0.5 1335 196 144 1 18* 5
Day 2
Food and water deprivation
Group 1 1.0 0.1 0 2616 168 146 1 276 39
Group II 1.3 0.3 0 2175 246 147 1 12* 3
Day 3
5% D/W
Group I 1.9 0.3 14.9 0.3 1622 205 115 3 285 SI
Group II 5.0 1.7 18.3* 0.3 1208 317 108 2 15* 5
* P < 0.01 compared to corresponding value in Group 1. Results are means SE of determinations on six rats in each group.
in the DDA VP-infused group as expected from previous results,
whereas in sham operated rats P[Na] decreased back to the
basal values observed on ad libitum food and water intake (140
I).
Since escape from the antidiuretic effect of DDAVP did not
occur in this rat model despite a marked increase in UPGE,V, we
considered the possibility that the magnitude of the antidiuresis
and resulting water retention might have been even greater in
the absence of the UPGE2V response to DDAVP. Additional
studies were conducted using the same protocol described in
the legend to Fig. 2. Some of the rats were treated with
indomethacin (7.5 mg/kg/day s.c.) beginning eight hrs before the
start of the study, while others received only the indomethacin
vehicle (50 mrvt Tris, pH 8.0). Following a period of ad libitum
food and water intake (Day I), all rats received DDAVP pumps
and were studied both during food and water deprivation (Day
2) and volume repletion (Day 3). As shown in Table 1, indo-
methacin suppressed basal UPGE,V 75 to 85% and abolished
increases induced by DDAVP, but did not significantly influ-
ence Uosmol or P[Na] under any of the conditions studied.
Although V tended to be higher on Day 3 in fluid repleted rats
receiving indomethacin, this difference did not reach statistical
significance. The higher value for V in rats receiving indometh-
acm plus DDAVP during fluid repletion was likely due to the
higher fluid intake in this group on Day 3 compared to rats
receiving DDAVP alone.
Discussion
The increase in UPGE,V observed in response to DDAVP in
the present study is consistent with previous data in the DI rat
[15, 20, 23] and with a single earlier study in normal rats [25].
We considered several possible explanations to account for this
response. Administration of DDAVP to rats deprived of food
and then allowed free access to 5% D/W resulted in a marked
and sustained reduction in P[Na1 and plasma renin activity, and
therefore probably a concurrent expansion in extra—cellular
fluid volume due to acute water retention. However, DDAVP
induced quantitatively similar increases in UPGE,V in rats
deprived of water as in those with a high fluid intake, which led
to marked water retention and hyponatremia. This implies that
the increase in UPGE,V in response to DDAVP is not mediated
by volume expansion. Deprivation of water per se clearly
increased endogenous antidiuretic hormone secretion as re-
flected by the high Uosm/Posm ratio in the water deprived rats
not treated with DDAVP (Fig. 2). Indeed, V and Uosm were not
significantly different in the water deprived rats given DDAVP
compared to those subjected to water deprivation alone. Con-
sistent with previous observations [13], water deprivation alone
did not result in an increase in UPGE2V compared to values
obtained in the same group of rats on ad libitum water intake.
Therefore, the increase in UPGE2V with DDAVP which we
observed in water deprived rats also cannot be attributable to
elevated circulating levels of endogenous antidiuretic hormone.
Previous studies describing increases in UPGE2V with
DDAVP hve often employed subjects with central DI[16, 20,
23, 24]. Kramer, Glanzer and Dusing have suggested that the
failure of some investigators to observe an increase in UPGE2V
with DDAVP may be related to the state of activation of the
renin—angiotensin system [16]. Thus, in hydrated subjects with
DI, plasma renin activity was low. This would be expected to
lead to a reduction in angiotensin II, and consequently a loss of
the influence of angiotensin II on UPGE2V. This in turn might
allow detection of an effect of DDAVP on UPCJE2V [16]. Such an
explanation is not supported by results of the present study.
The increases in UPGE2V with DDAVP were similar in rats
during fluid deprivation and water diuresis, conditions which
likely resulted in marked differences in the state of activation of
the renin—angiotensin system. Consequently, it seems most
likely that the increases in UPGE2V observed in this study
represented a direct effect of DDAVP on the kidney, rather than
a secondary stimulation by volume changes, endogenous vaso-
pressin or the renin—angiotensin system.
Previous observations from our own [14] and other [19]
laboratories have suggested that increases in UPGE2V occurring
with antidiuretic hormone may play a role in the mediation of
escape from inappropriate antidiuresis and water retention. In
the present study, we further examined this question employing
a different experimental model for inappropriate antidiuresis in
which escape from the antidiuretic effects of DDAVP is not
apparent [26]. As illustrated, UPGE2V rose during the first eight
hrs after the start of DDAVP infusion and remained elevated
during the succeeding two eight hr urine collections (Fig. 1).
However, despite a marked sustained increase in UPGE,V
throughout the DDAVP infusion, no secondary decline in Uosm
or increase in V was observed in association with the enhanced
UPGE2V.
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The basis for the apparent failure of rats to escape from the
antidiuretic effect of DDAVP observed in the present study
remains speculative. However, there are several potential ex-
planations for these observations. First, it is possible that in the
absence of the UPGE,V response to DDAVP, the magnitude of
antidiuresis and water retention might have been even greater.
However, this seems unlikely. In the present study, indometh-
acm did not significantly increase Uosmol or decrease V in
volume repleted rats receiving DDAVP as compared to values
obtained in rats receiving DDAVP alone. Indeed, after volume
repletion, V tended to be higher in rats receiving indomethacin
plus DDAVP, compared to the group receiving DDAVP alone,
probably due to a higher fluid intake in the indomethacin group.
Second, DDAVP and AVP may increase renal PGE2 production
by actions at different sites in the kidney (cortical collecting
duct versus medullary interstitial cells, respectively), [9, Il, 12]
or through different renal receptors, resulting in divergent net
physiologic effects of these two hormones. In this regard, it has
recently been suggested that escape from the antidiuretic action
of AVP is mediated by the pressor action of the hormone [33].
However, the latter also seems unlikely. Thus, Gross and
Anderson demonstrated that escape from inappropriate
antidiuresis occurred between 8 and 16 hrs after the start of
infusion of either DDAVP or AVP in conscious rats infused
with hypotonic fluid [IS]. Moreover, earlier work with the
present model failed to demonstrate escape in response to
either AVP or DDAVP despite the development of similar
degrees of hyponatremia and water retention [26]. A third
potential explanation for the apparent failure of DDAVP treated
rats to escape from antidiuresis in the present study is that there
may have been an insufficient volume stimulus for escape to
occur. Rats in the current study were given an i.p. bolus
injection of 20 mliter of 5% D/W and were then allowed access
to an additional 30 mliter of 5% D/W in their drinking bottles. In
the first eight hrs after the injection of 5% D/W, the rats drank
22 5 mliter followed by a sharp reduction in fluid intake to 1.7
1.4 and 1.7 0.5 mliter during the subsequent two eight hr
study periods. By contrast, in the study of Gross and Anderson
[25], rats received a continuous infusion of 72 mliter/day of
0.22% NaCI starting 24 hrs before DDAVP or AVP infusion.
Thus, the fluid volume administered in the Gross and Anderson
study was far greater than that in the present study, and this
difference may have contributed to the apparent failure of
hyponatremic rats to escape from the inappropriate antidiuresis
which we observed. Finally, food deprivation may also play a
role in the apparent failure of rats to escape from antidiuresis.
In our previous studies, the degree of hyponatremia achieved in
rats allowed free access to food and 5% D/W was much less
than that observed in rats deprived of food but allowed access
to 5% D/W [14, 26]. In this regard, in two previous models in
which rats were shown to escape from inappropriate
antidiuresis within eight hrs following administration of AVP or
DDAVP, food was provided ad libitum throughout the course of
the study [14, 25]. The mechanism by which food deprivation
might prevent escape is uncertain. However, it could be related
to the reduction in glomerular filtration rate and renal plasma
flow known to accompany protein deprivation [34], with the
resultant decrease in the ability of the rats to excrete free water
on this basis.
Whatever the mechanisms involved, our results indicate that
a rise in UPGE,V per se is not sufficient to trigger escape from
inappropriate antidiuresis. Our results also demonstrate that
DDAVP, an analogue of AVP with almost no pressor activity,
increased UPGE,V in rats that did not have central DI. This
therefore implies that the UPGE,V response to vasopressin may
be at least in part linked to the antidiuretic activity of the
hormone.
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